Old Web
English
Sign In
Acemap
>
authorDetail
>
M.A. Soubasakos
M.A. Soubasakos
Virology
Medicine
Diabetes mellitus
Protease
hcv protease
5
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
769 A TRIPLE COMBINATION OF DIRECT-ACTING ANTIVIRAL AGENTS DEMONSTRATES ROBUST ANTI-HCV ACTIVITY IN VITRO
2010
Journal of Hepatology
M. LaColla
L.B. Lallos
I Serra
J.P. Bilello
M.A. Soubasakos
A. Bonin
D.N. Standring
Show All
Source
Cite
Save
Citations (3)
344 PRECLINICAL PROFILES OF IDX136 AND IDX316, TWO NOVEL MACROCYCLIC HCV PROTEASE INHIBITORS
2009
Journal of Hepatology
L.B. Lallos
J.P. Bilello
M.A. Soubasakos
J. Gillum
M. La Colla
M. Liuzzi
J. Mc Carville
Maria Seifer
S.S. Good
M Larsson
J. Selden
Christophe Claude Parsy
Dominique Surleraux
D.N. Standring
Show All
Source
Cite
Save
Citations (1)
[793] COMBINATION OF TWO HEPATITIS C VIRUS INHIBITORS, SCH 503034 AND NM107, PROVIDES ENHANCED ANTI-REPLICON ACTIVITY AND SUPPRESSES EMERGENCE OF RESISTANT REPLICONS
2007
Journal of Hepatology
Robert Ralston
Vadim Bichko
Robert Chase
M. LaColla
L. Lallos
Angela Skelton
M.A. Soubasakos
M.M. Tausek
Xiao Tong
D.N. Standring
Show All
Source
Cite
Save
Citations (3)
[427] VALOPICITABINE (NM283) IS FULLY ACTIVE AGAINST KNOWN HCV PROTEASE RESISTANCE MUTATIONS IN VITRO
2007
Journal of Hepatology
Vadim Bichko
L. Lallos
M.A. Soubasakos
M. LaColla
M.M. Tausek
J. Gillum
D.N. Standring
Show All
Source
Cite
Save
Citations (7)
1